# MediPOS Owner vs Medeasy PH

The clearest difference is update cadence: Medeasy PH at every 3 weeks against MediPOS Owner's every 3 months. MediPOS Owner's advantage is iOS requirement (12.0 vs 15.5). On price, ads, in-app purchases and device support there is nothing between them.

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

MediPOS Owner ships an update every 3 months, Medeasy PH every 3 weeks. The most recent releases landed on November 7, 2026 and November 3, 2026 respectively.

## The numbers

| Metric | MediPOS Owner | Medeasy PH |
| --- | --- | --- |
| Price | Free | Free |
| In-app purchases | No | No |
| Ads | No | No |
| Update frequency | Every 3 months | **Every 3 weeks** |
| Size | 30 MB | 117 MB |
| Requires iOS | **12.0** | 15.5 |
| Devices | iPhone, iPod | iPhone, iPod |
| Age rating | 4+ | 17+ |
| Developer | [PULSE TECH LTD](https://appshunter.io/developer/1623117488) | [NVI HEALTH TECH CORPORATION](https://appshunter.io/developer/1648089689) |

## What reviewers say

### MediPOS Owner

[App page](https://appshunter.io/ios/app/medipos-owner/id1623117486)

**Features:** macOS Compatibility

**In-app purchases:** none


### Medeasy PH

[App page](https://appshunter.io/ios/app/medeasy-ph/id6443653585)

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases:** none


## Frequently asked questions

### Is MediPOS Owner free?

MediPOS Owner is free to download, with no in-app purchases.

### Is Medeasy PH free?

Medeasy PH is free to download, with no in-app purchases.

### Do MediPOS Owner or Medeasy PH have ads?

Neither MediPOS Owner nor Medeasy PH shows ads.

### Which is updated more often, MediPOS Owner or Medeasy PH?

MediPOS Owner ships an update every 3 months, and Medeasy PH every 3 weeks. Most recently, MediPOS Owner was updated on November 7, 2026 and Medeasy PH on November 3, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*